You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 145 No. 11, November 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatologic Disorders
 •Radiologic Imaging
 •Diagnosis
 •Magnetic Resonance Imaging
 •Vascular Malformations
 •Drug Therapy
 •Drug Therapy, Other
 •Genetics
 •Genetic Disorders
 •Hematology/ Hematologic Malignancies
 •Coagulation Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Relevance of D-dimer Testing in Patients with Venous Malformations

Sheilagh Maguiness, MD; Marion Koerper, MD; Ilona Frieden, MD

Arch Dermatol. 2009;145(11):1321-1324.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Venous malformations (VMs) are among the most common vascular malformations, second in frequency only to port-wine stains, and they are the most common vascular malformations seen in multidisciplinary vascular anomalies referral centers.1 They are structural anomalies of the venous vasculature that are composed of ectatic or aberrant venous channels deficient in smooth muscle cells. Most VMs are evident at birth, but a notable minority of patients present for the first time later in childhood or as adults. Although not a tumor per se,2 VMs may expand disproportionately to somatic growth. Some cases, both hereditary and sporadic, are due to mutations in Tie-2, an endothelial cell tyrosine kinase receptor, but many VMs do not show this mutation and are presumably due to other somatic or germ-line mutations. The concept of ongoing clotting within VMs is not new3-4; however, an increased appreciation . . . [Full Text of this Article]

COAGULOPATHY AS A DIAGNOSTIC TOOL


IMPLICATIONS FOR MANAGEMENT

AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Elevated D-dimer Level in the Differential Diagnosis of Venous Malformations
Anne Dompmartin, Fanny Ballieux, Pascal Thibon, Agnès Lequerrec, Cédric Hermans, Philippe Clapuyt, Marie-Thérèse Barrellier, Franck Hammer, Daniel Labbé, Miikka Vikkula, and Laurence M. Boon
Arch Dermatol. 2009;145(11):1239-1244.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.